Michael Dabrowski

Michael Dabrowski is the CEO and co-founder of Pelago Bioscience AB, specializing in Drug Discovery specialty services. Previously, Michael worked at AstraZeneca in various roles such as Project Generation Manager and Head of Ion Channel Initiative. With a background in electrophysiology and in vitro pharmacology, Michael has extensive experience in ion channel drug discovery. Michael holds a PhD in Electrophysiology and has completed an Executive Leadership Programme at the Stockholm School of Economics.